Literature DB >> 15502926

Substrates modified by advanced glycation end-products cause dysfunction and death in retinal pericytes by reducing survival signals mediated by platelet-derived growth factor.

A W Stitt1, S-J Hughes, P Canning, O Lynch, O Cox, N Frizzell, S R Thorpe, T G Cotter, T M Curtis, T A Gardiner.   

Abstract

AIMS/HYPOTHESIS: Premature death of retinal pericytes is a pathophysiological hallmark of diabetic retinopathy. Among the mechanisms proposed for pericyte death is exposure to AGE, which accumulate during diabetes. The current study used an in vitro model, whereby retinal pericytes were exposed to AGE-modified substrate and the mechanisms underlying pericyte death explored.
METHODS: Pericytes were isolated from bovine retinal capillaries and propagated on AGE-modified basement membrane (BM) extract or non-modified native BM. The extent of AGE modification was analysed. Proliferative responses of retinal pericytes propagated on AGE-modified BM were investigated using a 5-bromo-2-deoxy-uridine-based assay. The effect of extrinsically added platelet-derived growth factor (PDGF) isoforms on these proliferative responses was also analysed alongside mRNA expression of the PDGF receptors. Apoptotic death of retinal pericytes grown on AGE-modified BM was investigated using terminal deoxynucleotidyl transferase-mediated dUTP nick end-labelling labelling, mitochondrial membrane depolarisation and by morphological assessment. We also measured both the ability of PDGF to reverse Akt dephosphorylation that was mediated by AGE-modified BM, and increased pericyte apoptosis.
RESULTS: Retinal pericytes exposed to AGE-modified BM showed reduced proliferative responses in comparison to controls (p<0.05-0.01), although this effect was reversed at low-AGE modifications. PDGF mRNA levels were differentially altered by exposure to low and high AGE levels, and AGE-modified BM caused significantly increased apoptosis in retinal pericytes. Pre-treatment of AGE-modified BM with PDGF-AA and -BB reversed the apoptosis (p<0.05-0.001) and restored Akt phosphorylation in retinal pericytes. CONCLUSIONS/
INTERPRETATION: Evidence suggests that substrate-derived AGE such as those that occur during diabetes could have a major influence on retinal pericyte survival. During diabetic retinopathy, AGE modification of vascular BM may reduce bioavailability of pro-survival factors for retinal pericytes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15502926     DOI: 10.1007/s00125-004-1523-3

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  56 in total

1.  Pericyte loss and microaneurysm formation in PDGF-B-deficient mice.

Authors:  P Lindahl; B R Johansson; P Levéen; C Betsholtz
Journal:  Science       Date:  1997-07-11       Impact factor: 47.728

2.  Effect of cross-linking on matrix permeability. A model for AGE-modified basement membranes.

Authors:  J Boyd-White; J C Williams
Journal:  Diabetes       Date:  1996-03       Impact factor: 9.461

3.  The relationship of glycaemic level to advanced glycation end-product (AGE) accumulation and retinal pathology in the spontaneous diabetic hamster.

Authors:  H P Hammes; B Wellensiek; I Klöting; E Sickel; R G Bretzel; M Brownlee
Journal:  Diabetologia       Date:  1998-02       Impact factor: 10.122

4.  Beraprost sodium, a prostaglandin I2 analogue, protects against advanced gycation end products-induced injury in cultured retinal pericytes.

Authors:  Sho-ichi Yamagishi; Shinjiro Amano; Yosuke Inagaki; Tamami Okamoto; Masayoshi Takeuchi; Zenji Makita
Journal:  Mol Med       Date:  2002-09       Impact factor: 6.354

5.  Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility.

Authors:  J D Mott; R G Khalifah; H Nagase; C F Shield; J K Hudson; B G Hudson
Journal:  Kidney Int       Date:  1997-11       Impact factor: 10.612

6.  Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy.

Authors:  Maria Enge; Mattias Bjarnegård; Holger Gerhardt; Erika Gustafsson; Mattias Kalén; Noomi Asker; Hans-Peter Hammes; Moshe Shani; Reinhardt Fässler; Christer Betsholtz
Journal:  EMBO J       Date:  2002-08-15       Impact factor: 11.598

7.  A morphologic and autoradiographic study of cell death and regeneration in the retinal microvasculature of normal and diabetic rats.

Authors:  N K Sharma; T A Gardiner; D B Archer
Journal:  Am J Ophthalmol       Date:  1985-07-15       Impact factor: 5.258

Review 8.  Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor.

Authors:  I Vlodavsky; H Q Miao; B Medalion; P Danagher; D Ron
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

9.  PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis.

Authors:  H Boström; K Willetts; M Pekny; P Levéen; P Lindahl; H Hedstrand; M Pekna; M Hellström; S Gebre-Medhin; M Schalling; M Nilsson; S Kurland; J Törnell; J K Heath; C Betsholtz
Journal:  Cell       Date:  1996-06-14       Impact factor: 41.582

10.  The role of polyol pathway in glucose-induced apoptosis of cultured retinal pericytes.

Authors:  Kazuma Miwa; Jiro Nakamura; Yoji Hamada; Keiko Naruse; Eitaro Nakashima; Koichi Kato; Yasuhide Kasuya; Yutaka Yasuda; Hideki Kamiya; Nigishi Hotta
Journal:  Diabetes Res Clin Pract       Date:  2003-04       Impact factor: 5.602

View more
  19 in total

1.  Recombinant alpha2(IV)NC1 domain of type IV collagen is an effective regulator of retinal capillary endothelial cell proliferation and inhibits pre-retinal neovascularisation.

Authors:  Gary Coleman; Tom A Gardiner; Ariel Boutaud; Alan W Stitt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-08-17       Impact factor: 3.117

Review 2.  Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease.

Authors:  Joanna Kur; Eric A Newman; Tailoi Chan-Ling
Journal:  Prog Retin Eye Res       Date:  2012-05-03       Impact factor: 21.198

Review 3.  Retinal endothelial cell apoptosis.

Authors:  Jena J Steinle
Journal:  Apoptosis       Date:  2012-12       Impact factor: 4.677

Review 4.  Dietary hyperglycemia, glycemic index and metabolic retinal diseases.

Authors:  Chung-Jung Chiu; Allen Taylor
Journal:  Prog Retin Eye Res       Date:  2010-09-22       Impact factor: 21.198

5.  Müller glial dysfunction during diabetic retinopathy in rats is linked to accumulation of advanced glycation end-products and advanced lipoxidation end-products.

Authors:  T M Curtis; R Hamilton; P-H Yong; C M McVicar; A Berner; R Pringle; K Uchida; R Nagai; S Brockbank; A W Stitt
Journal:  Diabetologia       Date:  2010-11-30       Impact factor: 10.122

Review 6.  Diabetic retinopathy, superoxide damage and antioxidants.

Authors:  Julia M Santos; Ghulam Mohammad; Qing Zhong; Renu A Kowluru
Journal:  Curr Pharm Biotechnol       Date:  2011-03-01       Impact factor: 2.837

7.  [Protein glycation as a pathological mechanism in diabetes].

Authors:  A Simm; A Navarrete-Santos; B Hofmann; H Bushnaq; N Nass
Journal:  Z Gerontol Geriatr       Date:  2012-02       Impact factor: 1.281

8.  Advanced glycation of the Arg-Gly-Asp (RGD) tripeptide motif modulates retinal microvascular endothelial cell dysfunction.

Authors:  Denise M McDonald; Gary Coleman; Ashay Bhatwadekar; Tom A Gardiner; Alan W Stitt
Journal:  Mol Vis       Date:  2009-08-05       Impact factor: 2.367

Review 9.  Phosphoinositide 3-kinase signaling in the vertebrate retina.

Authors:  Raju V S Rajala
Journal:  J Lipid Res       Date:  2010-01       Impact factor: 5.922

Review 10.  Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives.

Authors:  Sally A Madsen-Bouterse; Renu A Kowluru
Journal:  Rev Endocr Metab Disord       Date:  2008-12       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.